Dexmethylphenidate Hydrochloride
CAS 40431-64-9 7 FDA-DMF suppliersSmall Molecule
Overview
Dexmethylphenidate Hydrochloride is the d-threo-enantiomer of the racemic methylphenidate hydrochloride, used as a central nervous system stimulant. It is primarily indicated for the treatment of attention deficit hyperactivity disorder (ADHD) in children and adults.
API suppliers (8)
Suppliers of Dexmethylphenidate Hydrochloride backed by a verifiable FDA Type II Drug Master File. Source: FDA quarterly DMF list.
- SIEGFRIED USA LLC1 active DMF
- SIEGFRIED USA LLC1 active DMF
- SIEGFRIED USA LLC1 active DMF
- PURISYS LLCUnited States1 active DMF
- CURIA MISSOURI INC1 active DMF
- CURIA MISSOURI INC1 active DMF
- SIEGFRIED USA LLC1 active DMF
- CURIA MISSOURI INC1 active DMF
Therapeutic areas
Attention Deficit Hyperactivity Disorder
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.